Prazosin Hydrochloride Blood Pressure Medication Recalled: Urgent Alert for Patients

Sandy
Prazosin Hydrochloride Blood Pressure Medication Recalled

Critical Health Alert: Prazosin Hydrochloride Blood Pressure Medication Recalled

Parsippany, NJ – A critical health alert was issued for patients to inform that capsules of Prazosin Hydrochloride Blood Pressure Medication Recalled. A widely prescribed medication for high blood pressure and off-label for PTSD-related nightmares. Teva Pharmaceuticals, a New Jersey-based manufacturer, has initiated a voluntary nationwide recall of over 580,000 bottles of the drug after discovering unacceptable levels of N-nitroso Prazosin impurity C, a chemical with the potential to cause cancer.

This recall, spanning various dosages and bottle sizes, highlights ongoing vigilance within the pharmaceutical industry to ensure drug safety and purity.

FDA: Drug recall information |
USA Today Coverage

What Happened: The Prazosin Recall Details

On October 29-30, 2025, Teva Pharmaceuticals USA recalled Prazosin Hydrochloride capsules (1 mg, 2 mg, and 5 mg strengths) after detecting N-nitroso Prazosin impurity C above regulatory intake limits. Nitrosamines, such as this impurity, can theoretically increase cancer risks with extended exposure.
The FDA classified this as a Class II recall, meaning temporary or reversible adverse health events may be possible, but serious health consequences are remote.

Scope of the Recall: Affected Products

  • 1 mg Capsules (Recall Number D-0104-2026): NDC 0093-4067-01 (100 capsules), NDC 0093-4067-10 (1,000 capsules), lots Oct 2025–Aug 2026, 181,659 bottles.
  • 2 mg Capsules (D-0105-2026): NDC 0093-4068-01 (100), NDC 0093-4068-10 (1,000), lots Oct 2025–Feb 2028, 291,512 bottles.
  • 5 mg Capsules (D-0106-2026): NDC 0093-4069-01 (100), NDC 0093-4069-52 (250), NDC 0093-4069-05 (500), lots Nov 2025–Feb 2027, 107,673 bottles.

For full recall details, see the FDA alert and Health.com.

Why It Matters: Impurities, Risk, and Context

Nitrosamines may be found naturally, but high levels in medication can prompt recalls due to cancer risk. The recall addresses N-nitroso Prazosin impurity C in Prazosin Hydrochloride.
No immediate cases of cancer or serious illness linked directly to this recall have been reported.
WSOC TV report

What Patients Need to Do: Essential Steps

  • Do not abruptly stop taking your blood pressure medication unless instructed by a physician (risk: uncontrolled hypertension).
  • Check Your Medication Bottle: Compare details on the label with the
    FDA recall page.
  • Contact Your Pharmacist and Doctor: To confirm whether your medication is affected and get safe, personalized advice.
    Internal link: Read our guide on handling drug recalls
  • Safe Disposal: Your pharmacist can advise on take-back programs if your medication is recalled. Patient guidance

In-Depth Analysis & Expert Commentary

Clinical Implications: Patient safety depends on balancing the risk of impurity exposure against the immediate risks of stopping prescribed medication. Always consult a healthcare provider before making changes.

Manufacturing & Quality: Nitrosamine formation often stems from solvents, process catalysts, or batch cross-contamination. This event underscores the ongoing need for strict safety testing.

Eating Well Coverage

Forecast: What’s Next?

Teva and the FDA continue to coordinate efforts to remove affected batches and support pharmacies and patients. Monitoring and further research will continue as new information emerges.

References & Sources

Disclaimer

Medical Disclaimer 
This article is for informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult your doctor, pharmacist, or another qualified health provider with any questions regarding your medication, health condition, or before making medical decisions. Never disregard professional advice or delay seeking it because of something you have read on this site.